Abstract
Chronic kidney disease (CKD) affects up to 16% of the adult population and is associated with significant morbidity and mortality. People at highest risk from progressive CKD are defined by a sustained decline in estimated glomerular filtration rate (eGFR) and/or the presence of significant albuminuria/proteinuria and/or more advanced CKD. Accurate mapping of the bio-clinical determinants of this group will enable improved risk stratification and direct the development of better targeted management for people with CKD.
Original language | English |
---|---|
Article number | 95 |
Journal | BMC Nephrology |
Volume | 14 |
DOIs | |
Publication status | Published - 25 Apr 2013 |